Edit |   |
---|---|
Antigenic Specificity | CA19-9 + CD3 (bispecific) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | n/a |
Format | bispecific |
Size | n/a |
Concentration | n/a |
Applications | FuncS; Promising therapeutic agent; |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Recombinant Human Anti-CA19-9 x Anti-CD3 Bispecific Antibody (CrossMab). Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget T cells to tumor cells. It is designed for the research of Ovarian cancer; Pancreatic cancer; Gastric cancer therapy. |
Immunogen | n/a |
Other Names | CA19-9; Cancer antigen 19-9; sialylated Lewis (a) antigen; Carbohydrate antigen 19-9 |
Gene, Accession # | n/a |
Catalog # | CROSSAB-H201 |
Price | please inquire |
Order / More Info | CA19-9 + CD3 (bispecific) Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |